Vicarious Surgical updates investor presentation; targets ventral hernia repair, reaches 63% system functionality

Vicarious Surgical Inc.

First build under control completed April 2025; second build completed August 2025 demonstrating scalability.
System functionality progressed from 49% (June) to 63% (September) toward 100%.
Next milestone: Production Equivalent System by mid-2026; Design Lock by year-end 2026.
Targeting 5.6M annual US abdominal procedures; 82% still non-robotic; initial focus on ventral hernia repair.
IP portfolio includes 43 granted/allowed patents and 87 pending, totaling 130 protections.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.